利用药剂学方法和栅控恒压电晕充电技术制备驻极体美洛昔康贴剂,考察驻极体美洛昔康贴剂经皮给药24 h内,美洛昔康在SD大鼠血液和肝脏组织中浓度的变化,探讨负极性驻极体对美洛昔康的透皮促渗效果.实验结果表明经皮给药24 h内,-2 000 V驻极体对美洛昔康的透皮促渗效果不明显;-1 200 V驻极体对美洛昔康的透皮吸收有明显的促渗作用,且促渗倍数为对照组4倍.
[1] 夏运岳, 潘建新, 顾振纶. 美洛昔康在大鼠体内的药代动力学研究 [J]. 中国药理学通报 2001.doi:10.3321/j.issn:1001-1978.2001.02.035
[2] Prausnitz MR, Langer R. Transdermal drug delivery [J]. Nature biotechnology 2008, 11(11).
[3] 郑俊民. 经皮给药新剂型 [M]. 北京:人民卫生出版社 2006.
[4] Bae JW, Kim MJ, Jang CG, Lee SY. Determination of meloxicam in human plasma using a HPLC method with UV detection and its application to a pharmacokinetic study [J]. Journal of chromatography, B. Analytical technologies in the biomedical and life sciences 2007, 1(1).
[5] JIANG Jian, KONG Yuxiu, CHENG Liang. Effect of electret on transdermal permeation of meloxicam from a patch formulation [A]. 上海 2008.